BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20216128)

  • 1. Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab.
    Wechalekar MD; Rischmueller M; Whittle S; Burnet S; Hill CL
    J Clin Rheumatol; 2010 Mar; 16(2):79-80. PubMed ID: 20216128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles of therapy in reactive arthritis].
    Braun J; Eggens U; Sieper J
    Wien Klin Wochenschr; 1994; 106(9):259-64. PubMed ID: 8023519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis].
    Quint KD; van der Helm-van Mil AH; Bergman W; Lavrijsen AP
    Ned Tijdschr Geneeskd; 2010; 154():A1614. PubMed ID: 20699017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection and musculoskeletal conditions: Reactive arthritis.
    Rihl M; Klos A; Köhler L; Kuipers JG
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1119-37. PubMed ID: 17127200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis.
    Meyer A; Chatelus E; Wendling D; Berthelot JM; Dernis E; Houvenagel E; Morel J; Richer O; Schaeverbeke T; Gottenberg JE; Sibilia J;
    Arthritis Rheum; 2011 May; 63(5):1274-80. PubMed ID: 21538314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study.
    Sieper J; Fendler C; Laitko S; Sörensen H; Gripenberg-Lerche C; Hiepe F; Alten R; Keitel W; Groh A; Uksila J; Eggens U; Granfors K; Braun J
    Arthritis Rheum; 1999 Jul; 42(7):1386-96. PubMed ID: 10403266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection.
    Schafranski MD
    Rheumatol Int; 2010 Mar; 30(5):679-80. PubMed ID: 19466419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of Chlamydia-induced reactive arthritis].
    Zarco Montejo P
    Reumatol Clin; 2012 Mar; 8 Suppl 1():S20-5. PubMed ID: 22421458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chlamydia-induced reactive arthritis--HLA-B 27 negative two patients].
    Kobayashi S; Suzuki S; Ueda A; Ushiyama C; Tamura N; Inoue H; Tsuda H; Takasaki Y; Hashimoto H
    Ryumachi; 1999 Feb; 39(1):11-6. PubMed ID: 10332211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive arthritis: a favorable 2 year course and outcome, independent of triggering agent and HLA-B27.
    Glennås A; Kvien TK; Melby K; Overbøo A; Andrup O; Karstensen B; Thoen JE
    J Rheumatol; 1994 Dec; 21(12):2274-80. PubMed ID: 7699628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactive arthritis associated with Chlamydia trachomatis infection: Importance of screening and treating the partner].
    Borges-Costa J; Pacheco D; Pereira F; Marques-Gomes M
    Actas Dermosifiliogr; 2010 Oct; 101(8):730-2. PubMed ID: 20965020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of reactive arthritis with infliximab].
    Abdelmoula LC; Yahia CB; Testouri N; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Dec; 86(12):1095-7. PubMed ID: 19213526
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactive Arthritis.
    Schmitt SK
    Infect Dis Clin North Am; 2017 Jun; 31(2):265-277. PubMed ID: 28292540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison.
    Carter JD; Valeriano J; Vasey FB
    J Rheumatol; 2004 Oct; 31(10):1973-80. PubMed ID: 15468362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive arthritis: clinical aspects and medical management.
    Carter JD; Hudson AP
    Rheum Dis Clin North Am; 2009 Feb; 35(1):21-44. PubMed ID: 19480995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reiter's syndrome. Description of 2 cases with Chlamydia trachomatis infection].
    Cantaluppi P; Filippi C; Scanzi G
    Minerva Med; 1991 Sep; 82(9):595-8. PubMed ID: 1945011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of an experimental Chlamydia trachomatis salpingitis model for evaluating the effectiveness of antibiotics and anti-inflammatory agents on fertility].
    Verhoest P; Orfila J; Bissac E
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3):309-14. PubMed ID: 9265054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving story of Chlamydia-induced reactive arthritis.
    Carter JD; Hudson AP
    Curr Opin Rheumatol; 2010 Jul; 22(4):424-30. PubMed ID: 20445454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of tetracycline therapy on the laboratory indices of chlamydia infection in Reiter's disease (preliminary report)].
    Khamraev AA; Pankratova VN; Brodinova NS; Orlova OE; Shubin SV
    Revmatologiia (Mosk); 1990; (1):17-21. PubMed ID: 2377858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.